Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
7.09
-0.23 (-3.14%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Seres Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
68135142181698765
Upgrade
Market Cap Growth
-34.01%-5.13%-21.59%-74.06%-8.81%-65.78%
Upgrade
Enterprise Value
105172169223541461
Upgrade
Last Close Price
7.0914.8816.6228.00112.00166.60
Upgrade
PE Ratio
11.0823.631043.26---
Upgrade
PS Ratio
86.14170.61---5.28
Upgrade
PB Ratio
1.533.0410.29-4.0364.715.82
Upgrade
P/TBV Ratio
1.543.0410.29-64.715.82
Upgrade
P/FCF Ratio
78.57155.62----
Upgrade
P/OCF Ratio
60.85120.51---114.40
Upgrade
EV/Sales Ratio
133.29218.29---3.18
Upgrade
EV/FCF Ratio
121.58199.11----
Upgrade
Debt / Equity Ratio
1.881.886.65-4.4315.080.37
Upgrade
Debt / FCF Ratio
95.9195.91----
Upgrade
Net Debt / Equity Ratio
0.840.844.41-1.58-1.74-1.84
Upgrade
Net Debt / EBITDA Ratio
-0.41-0.41-0.52-0.370.114.13
Upgrade
Net Debt / FCF Ratio
43.0143.01-0.41-0.560.0883.91
Upgrade
Asset Turnover
0.010.01---0.42
Upgrade
Quick Ratio
2.402.400.861.302.123.53
Upgrade
Current Ratio
2.562.560.941.782.283.69
Upgrade
Return on Equity (ROE)
19.64%19.64%---258.04%-42.83%
Upgrade
Return on Assets (ROA)
-42.25%-42.25%-30.43%-34.48%-31.96%-11.55%
Upgrade
Return on Capital Employed (ROCE)
-79.10%-79.10%-123.10%-75.10%-68.40%-23.70%
Upgrade
Earnings Yield
8.38%4.23%0.10%-62.84%-35.85%-8.57%
Upgrade
FCF Yield
1.27%0.64%-105.01%-69.26%-34.20%-0.38%
Upgrade
Buyback Yield / Dilution
-14.15%-14.16%-21.40%-18.44%-17.86%-14.93%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.